Birthplace
MERZİFON
Languages
ENGLISH
Medical Areas of Interest
- Anemias
- bleeding and clotting disorders
- acute and chronic leukemias
- lymph node cancers (lymphomas)
- multiple myeloma and other plasma cell diseases
- myelodysplastic syndrome
- polycythemia vera
- essential thrombocytosis
- myelofibrosis
Highlights
Assoc. Prof. Aysun Halaçoğlu was born in Merzifon in 1980. She completed her medical education at Ankara University Faculty of Medicine in 2004, earning the title of Medical Doctor; she completed her Internal Medicine specialization at Ankara Atatürk Training and Research Hospital in 2011, earning the title of Internal Medicine Specialist; and she completed her Hematology specialization at Ankara Başkent University Faculty of Medicine in 2014, earning the title of Hematology Specialist.
Having completed her mandatory service at Şişli Hamidiye Etfal Training and Research Hospital, Assoc. Prof. Aysun Halaçoğlu continued her studies in the field of hematology and received her bone marrow transplantation certificate and associate professorship title in 2024.
Assoc. Prof. Aysun Halaçoğlu currently works at Medipol Bahçelievler University Hospital, aiming to provide services with a current and scientifically based treatment approach based on her existing clinical experience.
Experiences
2023 - 2024
İstanbul Aydın University Florya Medical Park Hospital
2021 - 2023
Medicana Bahçelievler Hospital
2019 - 2021
İstinye University Gaziosmanpaşa Medical Park Hospital
2018 - 2019
Memorial Şişli Hospital
2015
Şişli Hamidiye Etfal Training and Research Hospital
Educations
2014
Başkent University Faculty of Medicine, Hematology Specialty Training
2011
Atatürk Training and Research Hospital, Internal Medicine Specialty Training
2004
Ankara University, Faculty of Medicine
Publications
A. Articles published in internationally peer-reviewed journals:
A1. Halaçoğlu A. Extranodal T/NK lymphoma nasal type: A case with thrombotic thrombocytopenic purpura-like syndrome and third cranial nerve palsy. JHAS 2024;
A2. Halaçoğlu A, Serefhanoglu S. Peripheral Blood Stem Cells Mobilization in Patients with Relapsed or Refractory Lymphomas: A Single-Center Experience. J Cancer Res Ther. 2024;20(3): 904-908.
A3. Halaçoğlu A. Associations Between M-Protein and Bone Marrow Fibrosis in Newly Diagnosed Multiple Myeloma. JHAS 2023;3(1): 25-28.
A4. Halaçoğlu A. Cyclophosphamıde–Etoposıde + G-csf Compared to G-csf Alone in Perıpheral Blood Stem Cell Mobılızatıon for Multıple Myeloma. Hematology and Disorders 2023;1(1): 1-5.
A5. Halaçoğlu A. Relationship Between First-line Treatment Response and Bone Marrow Fibrosis in Newly Diagnosed Multiple Myeloma. JHAS 2022;1(3): 107-110.
A6. Halaçoğlu A, Serefhanoglu S. Retrospective Comparison of Mitoxantrone-Melphalan and BEAM Conditioning Regimens Before Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphoma Patients. Indian J Hematol Blood Transfus. 2021;38(1): 92-98.
A7. Toprak SK, Karakuş S, Halaçoğlu A, Hasdemir E, Üner H. Erythema Annulare Centrifugum and Relapsing Polychondritis Associated with Acute Myeloid Leukemia: A Case Report. Turk J Hematol 2012;29(3): 293-296.
B. Papers presented at international scientific meetings and published in proceedings:
B1. Koca E, Öte EO, Üner A, Terzi YK, Halaçoğlu A, Çetiner D, Karakuş S, Şahin Fİ. Importance of MPL W515L mutation in diagnosis of myelofibrosis: a case report. 5th International Congress on Leukemia Lymphoma Myeloma: İstanbul, Turkey; 21/05/2015-23/05/2015. Turkish Society of Hematology, Proceedings & Abstract Book, abstract: 0259
B2. Koca E, Halaçoğlu A, Malkan ÜY, Arıca D, Karakuş S, Göker H, Haznedaroğlu İC, Sayınalp N, Büyükaşık Y. Prognostic factors for survival of elderly patients with acute myeloid leukemia after intensive chemotherapy: validation of 3 popular prognostic models. 56th ASH Annual Meeeting and Exposition: San Francisco, USA; 06/12/2014-09/12/2014. Blood 2014;124(21):5332.
B3. Kaya E, Karakuş S, Halaçoğlu A, Koca E, Toprak SK, Tutal E. Evaluation of chronic lymphocytic leukemia patients followed by hematology department of Baskent University: single center experience. 4th International Congress on Leukemia Lymphoma Myeloma: İstanbul, Turkey; 22/05/2013-25/05/2013.
B4. Savaş ÖÖ, Halaçoğlu A, Yılmazer TT, Suher M. Female pseudohermaphroditism case that applied with hypertension and gynecomastia. 8th Congress of the European Federation of Internal Medicine: Istanbul, Turkey; 27/05/2009-30/05/2009. European Journal of Internal Medicine 2009;20:182.
D. Articles published in national peer-reviewed journals:
D1. Halaçoğlu A, Özen M., Ergönül Önder, Ural AU. ABO incomplete antibodies for COVID-19. Experimental Biomedical Research 2025;8(1): 33–39.
D2. Halaçoğlu A. Effect of Mannose-Binding Lectin Gene Polymorphism on Infection in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation. İstanbul Medical Journal 2023;24(3): 286-289.
D3. Halaçoğlu A, Suher M. The relationship between regulation of diabetes mellitus and osteoporosis. Yeni Tıp Dergisi 2012;29(4): 206-209.
D4. Halaçoğlu A, Suher M. The relationship between regulation of diabetes mellitus and serum trace elements. Yeni Tıp Dergisi 2012;29(1): 47-49.
D5. Erzurum C, Halaçoğlu A, Yılmazer TT, Suher M. Comparison of anthropometric measurements, high-sensitivity CRP and uric acid levels in obese patients with and without metabolic syndrome. Yeni Tıp Dergisi 2011;28(2): 101-104.
D6. Çamur B, Tüzün D, Kabaçam G, Halaçoğlu A, Yılmazer TT, Suher M. Causes of bleeding and risk factors in patients with upper gastrointestinal system bleeding. Medical Network Dahili Tıp 2008; 3(2): 87-92.
E. Papers presented at national scientific meetings and published in proceedings:
E1. Halaçoğlu A, Şerefhanoğlu S. Our experience with blinatumomab in relapsed acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: Oral presentation: 7th Hematologic Oncology Congress; 11/12/2020-13/12/2020.
E2. Halaçoğlu A. Consolidation therapy in Hodgkin lymphoma. For whom?, When?, For how long? Invited Speaker: 3rd Rare Hematologic Diseases Congress; 25/12/2020-27/12/2020.
E3. Halaçoğlu A. Apheresis indications: What does the 2019 ASFA guideline say? Invited Speaker: 3rd Rare Hematologic Diseases Congress; 25/12/2020-27/12/2020.
E4. Halaçoğlu A, Şerefhanoğlu S. Relapse with isolated spinal granulocytic sarcoma in a patient in remission with full chimerism after allogeneic stem cell transplantation: Oral presentation: 3rd Rare Hematologic Diseases Congress; 25/12/2020-27/12/2020.
E5. Eryılmaz ÖT, Halaçoğlu A, Özkayalar H, Kabukçuoğlu F. HHV-8 positive multicentric Castleman disease in an HIV positive patient: Case report. 28th National Pathology Congress: Ankara, Turkey; 27/10/2018-30/10/2018.
E6. Eryılmaz ÖT, Halaçoğlu A, Özkayalar H, Kabukçuoğlu F. Methotrexate-associated diffuse large B-cell lymphoma: Case report. 28th National Pathology Congress: Ankara, Turkey; 27/10/2018-30/10/2018.
E7. Halaçoğlu A, Karakuş S, Koca E, Arıca D, Ayhan A, Üner A. A case of relapsed primary hepatosplenic CD5 positive diffuse large B-cell lymphoma. 40th National Hematology Congress: Antalya, Turkey; 22/10/2014-25/10/2014.
E8. Halaçoğlu A, İzci T, Arıca D, Koca E, Karakuş S. Pregnancy and treatment management of chronic myeloproliferative disease, a case report. 40th National Hematology Congress: Antalya, Turkey; 22/10/2014-25/10/2014.
E9. Arıca D, Halaçoğlu A, Üner A, Nar A, Koca E, Karakuş S. A case of grade IIIA follicular lymphoma presenting with isolated splenic involvement. 40th National Hematology Congress: Antalya, Turkey; 22/10/2014-25/10/2014.
E10. Or A, Halaçoğlu A, Arıca D, Koca E, Karakuş S. Evaluation of women referred to the hematology clinic due to recurrent pregnancy loss in terms of acquired and hereditary thrombophilia. 40th National Hematology Congress: Antalya, Turkey; 22/10/2014-25/10/2014.
E11. Akıncıoğlu P, Koca E, Dağlı Ü, Bayraktar N, Halaçoğlu A, Arıca D, Yazıcı A, Karakuş S. Investigation of serum hepcidin level in inflammatory bowel diseases and comparison with fecal calprotectin in terms of disease activity. 40th National Hematology Congress: Antalya, Turkey; 22/10/2014-25/10/2014.
E12. Çelik B, Koca E, Anıl C, Bayraktar N, Halaçoğlu A, Arıca D, Yazıcı A, Karakuş S. In vitro evaluation of platelet aggregation dysfunction with ASPI/ADP tests in patients with thyroid hormone dysfunction. 40th National Hematology Congress: Antalya, Turkey; 22/10/2014-25/10/2014.
E13. Halaçoğlu A, Karakuş S, Koca E, Toprak SK, Özkan EA. A case of acute promyelocytic leukemia relapsing with a different subtype. 39th National Hematology Congress: Antalya, Turkey; 23/10/2013-26/10/2013.
E14. Halaçoğlu A, Toprak SK, Koca E, Karakuş S. Coexistence of primary central nervous system lymphoma and papillary thyroid carcinoma. 39th National Hematology Congress: Antalya, Turkey; 23/10/2013-26/10/2013.
E15. Oygür ÇŞ, Koca E, Halaçoğlu A, Gülel MŞ, Dönmez FY, Toprak SK, Karakuş S. Pain palliation after bone marrow biopsy. 39th National Hematology Congress: Antalya, Turkey; 23/10/2013-26/10/2013.
E16. Halaçoğlu A, Suher M, Beştepe N. Causes of hemodialysis and risk factors in patients undergoing emergency hemodialysis. 12th National Internal Medicine Congress: Antalya, Turkey; 06/10/2010-10/01/2010.
E17. Halaçoğlu A, Tüzün D, Kabaçam G, Yılmazer TT, Aydın OD, Suher M. Serious complications due to Lida use. 9th National Internal Medicine Congress: Antalya, Turkey; 05/09/2007-09/09/2007.
G. Other publications:
G1. A Halaçoğlu. Thalassemia in pregnancy. Sağlıkta Adres Başkent 2013;13:12-15.
Memberships
- Turkish Hematology Association
- Turkish Medical Association
Scientific Activities
"A.Articles published in international peer-reviewed journals:
A1. Halaçoğlu A, Köroğlu M, Özen M. Ceftazidime-avibactam use in hematology patients: single-center experience. Eur J Clin Microbiol Infect Dis 2025. doi: 10.1007/s10096-025-05107-7.
A2. Halaçoğlu A. Extranodal T/NK lymphoma nasal type: A case with thrombotic thrombocytopenic purpura-like syndrome and third cranial nerve palsy. JHAS 2024;5(1):109-110.
A3. Halaçoğlu A, Serefhanoglu S. Peripheral Blood Stem Cells Mobilization in Patients with Relapsed or Refractory Lymphomas: A Single-Center Experience. J Cancer Res Ther. 2024;20(3): 904-908.
A4. Halaçoğlu A. Associations Between M-Protein and Bone Marrow Fibrosis in Newly Diagnosed Multiple Myeloma. JHAS 2023;3(1): 25-28.
A5. Halaçoğlu A. Cyclophosphamıde–Etoposıde + G-csf Compared to G-csf Alone in Perıpheral Blood Stem Cell Mobılızatıon for Multıple Myeloma. Hematology and Disorders 2023;1(1): 1-5.
A6. Halaçoğlu A. Relationship Between First-line Treatment Response and Bone Marrow Fibrosis in Newly Diagnosed Multiple Myeloma. JHAS 2022;1(3): 107-110.
A7. Halaçoğlu A, Serefhanoglu S. Retrospective Comparison of Mitoxantrone-Melphalan and BEAM Conditioning Regimens Before Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphoma Patients. Indian J Hematol Blood Transfus. 2021;38(1): 92-98.
A8. Toprak SK, Karakuş S, Halaçoğlu A, Hasdemir E, Üner H. Erythema Annulare Centrifugum and Relapsing Polychondritis Associated with Acute Myeloid Leukemia: A Case Report. Turk J Hematol 2012;29(3): 293-296.
B. Papers presented at international scientific meetings and published in proceedings:
B1. Koca E, Öte EO, Üner A, Terzi YK, Halaçoğlu A, Çetiner D, Karakuş S, Şahin Fİ. Importance of MPL W515L mutation in diagnosis of myelofibrosis: a case report. 5th International Congress on Leukemia Lymphoma Myeloma: İstanbul, Turkey; 21/05/2015-23/05/2015. Turkish Society of Hematology, Proceedings & Abstract Book, abstract: 0259
B2. Koca E, Halaçoğlu A, Malkan ÜY, Arıca D, Karakuş S, Göker H, Haznedaroğlu İC, Sayınalp N, Büyükaşık Y. Prognostic factors for survival of elderly patients with acute myeloid leukemia after intensive chemotherapy: validation of 3 popular prognostic models. 56th ASH Annual Meeeting and Exposition: San Francisco, USA; 06/12/2014-09/12/2014. Blood 2014;124(21):5332.
B3. Kaya E, Karakuş S, Halaçoğlu A, Koca E, Toprak SK, Tutal E. Evaluation of chronic lymphocytic leukemia patients followed by hematology department of Baskent University: single center experience. 4th International Congress on Leukemia Lymphoma Myeloma: İstanbul, Turkey; 22/05/2013-25/05/2013.
B4. Savaş ÖÖ, Halaçoğlu A, Yılmazer TT, Suher M. Female pseudohermaphroditism case that applied with hypertension and gynecomastia. 8th Congress of the European Federation of Internal Medicine: Istanbul, Turkey; 27/05/2009-30/05/2009. European Journal of Internal Medicine 2009;20:182.
D. Articles published in national peer-reviewed journals:
D1. Halaçoğlu A, Özen M., Ergönül Ö, Ural AU. ABO incomplete antibodies for COVID-19. Experimental Biomedical Research 2025;8(1): 33–39.
D2. Halaçoğlu A. Effect of Mannose-Binding Lectin Gene Polymorphism on Infection in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation. İstanbul Medical Journal 2023;24(3): 286-289.
D3. Halaçoğlu A, Suher M. Diyabetes mellitus regülasyonunun osteoporoz ile ilişkisi. Yeni Tıp Dergisi 2012;29(4): 206-209.
D4. Halaçoğlu A, Suher M. Diyabetes mellitus regülasyonunun serum eser elementleri ile ilişkisi. Yeni Tıp Dergisi 2012;29(1): 47-49.
D5. Erzurum C, Halaçoğlu A, Yılmazer TT, Suher M. Metabolik sendromu olan ve olmayan obez hastaların antropometrik ölçümleri, yüksek sensitif CRP ve ürik asit düzeyleri açısından karşılaştırılması. Yeni Tıp Dergisi 2011;28(2): 101-104.
D6. Çamur B, Tüzün D, Kabaçam G, Halaçoğlu A, Yılmazer TT, Suher M. Üst gastrointestinal sistem kanamalı hastalarda kanama nedenleri ve risk faktörleri. Medical Network Dahili Tıp 2008; 3(2): 87-92.
E. Papers presented at national scientific meetings and published in proceedings:
E1. Halaçoğlu A, Şerefhanoğlu S. Allojeneik hematopoetik kök hücre nakli sonrası nüks akut lenfoblastik lösemide blinatumomab deneyimimiz: Sözel bildiri: 7. Hematolojik Onkoloji Kongresi; 11/12/2020-13/12/2020.
E2. Halaçoğlu A. Hodgkin lenfomada konsolidasyon tedavisi. Kime?, Ne zaman?, Ne kadar süre? Davetli Konuşmacı: 3. Hematolojik Nadir Hastalıklar Kongresi; 25/12/2020-27/12/2020.
E3. Halaçoğlu A. Aferez endikasyonları: 2019 ASFA rehberi ne diyor? Davetli Konuşmacı: 3. Hematolojik Nadir Hastalıklar Kongresi; 25/12/2020-27/12/2020.
E4. Halaçoğlu A, Şerefhanoğlu S. Allojeneik kök hücre nakli sonrası remisyonda ve tam kimerik hastanın izole spinal granülositik sarkom ile nüksü: Sözel bildiri: 3. Hematolojik Nadir Hastalıklar Kongresi; 25/12/2020-27/12/2020.
E5. Eryılmaz ÖT, Halaçoğlu A, Özkayalar H, Kabukçuoğlu F. HIV pozitif hastada HHV-8 pozitif multisentrik Castleman hastalığı: Olgu sunumu. 28. Ulusal Patoloji Kongresi: Ankara, Türkiye; 27/10/2018-30/10/2018.
E6. Eryılmaz ÖT, Halaçoğlu A, Özkayalar H, Kabukçuoğlu F. Methotreksat ilişkili diffüz büyük B hücreli lenfoma: Olgu sunumu. 28. Ulusal Patoloji Kongresi: Ankara, Türkiye; 27/10/2018-30/10/2018.
E7. Halaçoğlu A, Karakuş S, Koca E, Arıca D, Ayhan A, Üner A. Relaps primer hepatosplenik CD5 pozitif diffüz büyük B hücreli lenfoma olgusu. 40. Ulusal Hematoloji Kongresi: Antalya, Türkiye; 22/10/2014-25/10/2014.
E8. Halaçoğlu A, İzci T, Arıca D, Koca E, Karakuş S. Gebelik ve kronik myeloproliferatif hastalık tedavi yönetimi, bir olgu sunumu. 40. Ulusal Hematoloji Kongresi: Antalya, Türkiye; 22/10/2014-25/10/2014.
E9. Arıca D, Halaçoğlu A, Üner A, Nar A, Koca E, Karakuş S. İzole splenik tutulum ile karşımıza çıkan bir folliküler derece IIIA lenfoma olgusu. 40. Ulusal Hematoloji Kongresi: Antalya, Türkiye; 22/10/2014-25/10/2014.
E10. Or A, Halaçoğlu A, Arıca D, Koca E, Karakuş S. Tekrarlayan gebelik kaybı nedeniyle hematoloji kliniğine refere edilen kadınların edinsel ve kalıtsal trombofili açısından değerlendirilmesi. 40. Ulusal Hematoloji Kongresi: Antalya, Türkiye; 22/10/2014-25/10/2014.
E11. Akıncıoğlu P, Koca E, Dağlı Ü, Bayraktar N, Halaçoğlu A, Arıca D, Yazıcı A, Karakuş S. Serum hepsidin seviyesinin inflamatuar barsak hastalıklarında incelenmesi ve hastalık aktivasyonu açısından fekal kalprotektin ile karşılaştırılması. 40. Ulusal Hematoloji Kongresi: Antalya, Türkiye; 22/10/2014-25/10/2014.
E12. Çelik B, Koca E, Anıl C, Bayraktar N, Halaçoğlu A, Arıca D, Yazıcı A, Karakuş S. Tiroid hormon disfonksiyonu olan hastalarda trombosit agregasyon bozukluğunun in vitro olarak ASPİ/ADP testleri ile değerlendirilmesi. 40. Ulusal Hematoloji Kongresi: Antalya, Türkiye; 22/10/2014-25/10/2014.
E13. Halaçoğlu A, Karakuş S, Koca E, Toprak SK, Özkan EA. Farklı alt tipte relaps olan akut promyelositik lösemi olgusu. 39. Ulusal Hematoloji Kongresi: Antalya, Türkiye; 23/10/2013-26/10/2013.
E14. Halaçoğlu A, Toprak SK, Koca E, Karakuş S. Primer santral sinir sistem lenfoması ve tiroid papiller karsinomu birlikteliği. 39. Ulusal Hematoloji Kongresi: Antalya, Türkiye; 23/10/2013-26/10/2013.
E15. Oygür ÇŞ, Koca E, Halaçoğlu A, Gülel MŞ, Dönmez FY, Toprak SK, Karakuş S. Kemik iliği biyopsisi sonrası ağrı palyasyonu. 39. Ulusal Hematoloji Kongresi: Antalya, Türkiye; 23/10/2013-26/10/2013.
E16. Halaçoğlu A, Suher M, Beştepe N. Acil hemodiyalize alınan hastalarda hemodiyaliz nedenleri ve risk faktörleri. 12. Ulusal İç Hastalıkları Kongresi: Antalya, Türkiye; 06/10/2010-10/01/2010.
E17. Halaçoğlu A, Tüzün D, Kabaçam G, Yılmazer TT, Aydın OD, Suher M. Lida kullanımına bağlı gelişen ciddi komplikasyonlar. 9. Ulusal İç Hastalıkları Kongresi: Antalya, Türkiye; 05/09/2007-09/09/2007.
G. Other publications:
G1. A Halaçoğlu. Gebelikte talasemi. Sağlıkta Adres Başkent 2013;13:12-15."
Certifications
- Bone marrow transplant certificate
Additional Information
- Bone marrow and peripheral blood smear examination, chemotherapy and immunotherapy treatments.